2m 2m 2m 2m 2m 2m 2m
AMARIN SP ADR (AMRN)
NASDAQ
$11.64-$0.11 (-0.90%)
Price as of Nov 11, 2026 7:55 PM EST- $494.0MMarket Cap
- -26.97%1-Year Change
- Drug Manufacturers - GeneralIndustry
AMARIN SP ADR (AMRN)
$11.64-$0.11 (-0.90%)
AMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.75 | ||
Change | +$0.010 (+0.09%) | ||
Open | $11.67 | ||
High | $11.82 | ||
Low | $11.46 | ||
Previous Close | $11.74 | ||
Volume | 81,223 | ||
30-Day Average Volume | 81,235 | ||
1-Week Change | -2.49% | ||
1-Month Change | -2.33% | ||
1-Year Change | -26.97% | ||
3-Year Change | -18.90% | ||
5-Year Change | -86.01% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $634.1M | ||
Market Cap | $494.0M | ||
Enterprise Value | $337.5M | ||
Period: QTR TTM FY | |||
Revenue | $36.9M | ||
Net Income | $245,000.00 | ||
Free Cash Flow | $9.2M | ||
EBIT | $315,000.00 | ||
EBITDA | $952,000.00 | ||
Net Working Capital | $437.7M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 355 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 54 | ||
Price/Operating Cash Flow | 54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 04/11/2025 | ||
Earnings & Revenue